Martin Mackay is leaving his spot as the head of research and development at Pfizer to join AstraZeneca, where he will serve in the same capacity, reports Fierce Biotech.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.